Globeimmune Inc GBIM:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 03/14/24 EDT
0.00UNCH (UNCH)
52 week range
0.00 - 0.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date05/01/23
  • 52 Week Low0.00
  • 52 Week Low Date03/14/24

Key Stats

  • Market Cap5.752
  • Shares Out5.75M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta1.80
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date05/01/23
  • 52 Week Low0.00
  • 52 Week Low Date03/14/24
  • Market Cap5.752
  • Shares Out5.75M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta1.80
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.39
  • P/E (TTM)-0.00
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-1.941M
  • ROE (TTM)-66.24%
  • Revenue (TTM)6.213M
  • Gross Margin (TTM)97.95%
  • Net Margin (TTM)-33.30%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Globeimmune Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
GlobeImmune Inc. is a biopharmaceutical company. The Company is focused on developing products for the treatment of cancer and infectious diseases based on its Tarmogen platform. The Company’s Tarmogen platform activates the immune system by stimulating a subset of white blood cells called T cells that destroy infected or malignant cells in contrast to traditional vaccines, which predominately stimulate antibody production. Tarmogens also reduce the number and function of...
J. William Freytag Ph.D.
Independent Chairman of the Board
Timothy Rodell M.D.
President, Chief Executive Officer, Director
C. Jeffrey Dekker CPA
Vice President - Finance, Treasurer, Secretary
Address
1450 Infinite Drive
Louisville, CO
80027
United States